103 related articles for article (PubMed ID: 12566162)
1. Flurbiprofen inhibits capsaicin induced calcitonin gene related peptide release from rat spinal cord via an endocannabinoid dependent mechanism.
Seidel K; Hamza M; Ates M; Gühring H
Neurosci Lett; 2003 Feb; 338(2):99-102. PubMed ID: 12566162
[TBL] [Abstract][Full Text] [Related]
2. Intrathecally applied flurbiprofen produces an endocannabinoid-dependent antinociception in the rat formalin test.
Ates M; Hamza M; Seidel K; Kotalla CE; Ledent C; Gühring H
Eur J Neurosci; 2003 Feb; 17(3):597-604. PubMed ID: 12581177
[TBL] [Abstract][Full Text] [Related]
3. Spinal modulation of calcitonin gene-related peptide by endocannabinoids in the development of opioid physical dependence.
Trang T; Ma W; Chabot JG; Quirion R; Jhamandas K
Pain; 2006 Dec; 126(1-3):256-71. PubMed ID: 16935424
[TBL] [Abstract][Full Text] [Related]
4. The effect of cannabinoids on capsaicin-evoked calcitonin gene-related peptide (CGRP) release from the isolated paw skin of diabetic and non-diabetic rats.
Ellington HC; Cotter MA; Cameron NE; Ross RA
Neuropharmacology; 2002 Jun; 42(7):966-75. PubMed ID: 12069907
[TBL] [Abstract][Full Text] [Related]
5. Capsaicin-evoked prostaglandin E2 release in spinal cord slices: relative effect of cyclooxygenase inhibitors.
Malmberg AB; Yaksh TL
Eur J Pharmacol; 1994 Dec; 271(2-3):293-9. PubMed ID: 7705429
[TBL] [Abstract][Full Text] [Related]
6. CB(1) receptor antagonist SR141716A increases capsaicin-evoked release of Substance P from the adult mouse spinal cord.
Lever IJ; Malcangio M
Br J Pharmacol; 2002 Jan; 135(1):21-4. PubMed ID: 11786475
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory mediators do not stimulate CGRP release if prostaglandin synthesis is blocked by S(+)-flurbiprofen in isolated rat skin.
Averbeck B; Peisler M; Izydorczyk I; Reeh PW
Inflamm Res; 2003 Dec; 52(12):519-23. PubMed ID: 14991081
[TBL] [Abstract][Full Text] [Related]
8. S+ -flurbiprofen but not 5-HT1 agonists suppress basal and stimulated CGRP and PGE2 release from isolated rat dura mater.
Zimmermann K; Reeh WP; Averbeck B
Pain; 2003 Jun; 103(3):313-320. PubMed ID: 12791437
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
Herradón E; Martín MI; López-Miranda V
Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of the vanilloid receptor in the rat dorsal spinal cord.
Wardle KA; Ranson J; Sanger GJ
Br J Pharmacol; 1997 Jul; 121(5):1012-6. PubMed ID: 9222561
[TBL] [Abstract][Full Text] [Related]
11. Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide.
Price TJ; Patwardhan A; Akopian AN; Hargreaves KM; Flores CM
Br J Pharmacol; 2004 Apr; 141(7):1118-30. PubMed ID: 15006899
[TBL] [Abstract][Full Text] [Related]
12. Interactions of inflammatory mediators stimulating release of calcitonin gene-related peptide, substance P and prostaglandin E(2) from isolated rat skin.
Averbeck B; Reeh PW
Neuropharmacology; 2001 Mar; 40(3):416-23. PubMed ID: 11166334
[TBL] [Abstract][Full Text] [Related]
13. Effects of COX-2 inhibition on spinal nociception: the role of endocannabinoids.
Staniaszek LE; Norris LM; Kendall DA; Barrett DA; Chapman V
Br J Pharmacol; 2010 Jun; 160(3):669-76. PubMed ID: 20590570
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory CB1 and activating/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin.
Engel MA; Izydorczyk I; Mueller-Tribbensee SM; Becker C; Neurath MF; Reeh PW
Neuropeptides; 2011 Jun; 45(3):229-37. PubMed ID: 21514666
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of noxious stimulus-induced spinal prostaglandin E2 release by flurbiprofen enantiomers: a microdialysis study.
Geisslinger G; Muth-Selbach U; Coste O; Vetter G; Schrödter A; Schaible HG; Brune K; Tegeder I
J Neurochem; 2000 May; 74(5):2094-100. PubMed ID: 10800954
[TBL] [Abstract][Full Text] [Related]
16. (S)-AMPA inhibits electrically evoked calcitonin gene-related peptide (CGRP) release from the rat dorsal horn: reversal by cannabinoid receptor antagonist SR141716A.
Brooks JW; Thompson SW; Rice AS; Malcangio M
Neurosci Lett; 2004 Nov; 372(1-2):85-8. PubMed ID: 15531093
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid inhibition of capsaicin-sensitive sensory neurotransmission in the rat mesenteric arterial bed.
Ralevic V; Kendall DA
Eur J Pharmacol; 2001 Apr; 418(1-2):117-25. PubMed ID: 11334873
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries.
White R; Ho WS; Bottrill FE; Ford WR; Hiley CR
Br J Pharmacol; 2001 Oct; 134(4):921-9. PubMed ID: 11606334
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of fatty acid amide hydrolase and cyclooxygenase by the N-(3-methylpyridin-2-yl)amide derivatives of flurbiprofen and naproxen.
Cipriano M; Björklund E; Wilson AA; Congiu C; Onnis V; Fowler CJ
Eur J Pharmacol; 2013 Nov; 720(1-3):383-90. PubMed ID: 24120370
[TBL] [Abstract][Full Text] [Related]
20. A role for endocannabinoids in indomethacin-induced spinal antinociception.
Gühring H; Hamza M; Sergejeva M; Ates M; Kotalla CE; Ledent C; Brune K
Eur J Pharmacol; 2002 Nov; 454(2-3):153-63. PubMed ID: 12421642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
